Ground glass opacity (GGO) is a hazy, clouded area seen on a CT scan of the lungs. It looks like frosted glass: you can still see the outlines of blood vessels and airways through it, unlike a solid white patch that blocks everything from view. The term describes an appearance on imaging, not a specific disease. Many different conditions can cause it, ranging from temporary infections to chronic lung problems to early-stage cancer.
What Creates the Hazy Appearance
Your lungs are made of millions of tiny air sacs called alveoli, surrounded by thin walls of tissue. On a normal CT scan, these air-filled sacs appear dark because air doesn’t block X-rays. Ground glass opacity shows up when something partially fills or thickens these structures without completely replacing the air inside them. That partial filling is what creates the haze rather than a solid white patch.
The underlying changes in the tissue typically involve thickening of the walls between air sacs, sometimes with mild fluid accumulation or cellular growth inside the sacs themselves. Because some air remains, the lung tissue appears translucent rather than opaque. This is a key distinction radiologists use: if the haze is dense enough to completely hide the blood vessels behind it, it’s called consolidation rather than ground glass opacity, and it suggests a more advanced process like a fully developed pneumonia.
Common Causes
The list of conditions that produce ground glass opacity is long, which is why a single CT finding rarely points to one diagnosis on its own. Broadly, the causes fall into a few categories: infections, inflammation, fluid buildup, and abnormal cell growth.
Infections are among the most frequent culprits. Viral pneumonias, bacterial infections, and fungal lung infections can all produce areas of ground glass. During the COVID-19 pandemic, bilateral ground glass opacities became one of the hallmark CT findings. These infection-related opacities are often temporary, clearing as the illness resolves.
Fluid in the lungs from heart problems is actually the most commonly encountered vascular cause. When the heart struggles to pump efficiently, pressure backs up into the lung’s blood vessels, pushing fluid into the surrounding tissue and air sacs. On CT, this typically appears as hazy patches concentrated around the center of the chest and in the lower, gravity-dependent portions of the lungs. The alveolar walls become swollen with fluid, and the air sacs themselves partially fill with leaked plasma.
Inflammatory conditions affecting the lung tissue itself, grouped under the umbrella of interstitial lung disease, also produce ground glass opacity. In these cases, the haze can signal active inflammation, which is potentially treatable, as opposed to established scarring (fibrosis), which is not reversible.
Vaping-related lung injury (known as EVALI) emerged as a newer cause in recent years. CT scans in affected patients characteristically show bilateral ground glass opacities concentrated in the lower lungs, often with a distinctive pattern where the tissue directly beneath the chest wall is spared. Thickening of the airway walls and signs of airway inflammation are also typical. In one case series, 100% of EVALI patients who underwent CT had abnormal findings with bilateral ground glass as the defining feature.
When GGO Appears as a Nodule
Sometimes ground glass opacity doesn’t spread across a broad area but instead appears as a small, discrete round patch, called a ground glass nodule. These nodules get extra attention because they can represent early-stage lung cancer, specifically a type called adenocarcinoma.
The proposed progression works like this: abnormal but not yet cancerous cells begin growing in a small area of lung tissue, creating a faint ground glass nodule. Over time, sometimes years, these cells may progress through stages of increasing abnormality, from precancerous changes to a noninvasive form of cancer and eventually to invasive adenocarcinoma. This progression is slow. Many ground glass nodules never advance at all.
Radiologists pay close attention to whether a nodule is “pure” ground glass (entirely hazy with no solid center) or “part-solid” (a hazy nodule with a dense core). Part-solid nodules carry a higher concern for malignancy because that solid component can indicate more aggressive, invasive growth. However, even pure ground glass nodules under 30 mm are not automatically benign. A systematic review of over 3,800 patients found that pure ground glass nodules in this size range harbored a surprisingly high proportion of invasive cancer, with rates reaching up to 76% in some study populations. This wide range reflects differences in which patients were studied and how nodules were selected for biopsy, but it underscores why these findings aren’t simply dismissed.
Transient vs. Persistent: Why Follow-Up Matters
One of the most important questions after a ground glass opacity is found is whether it will go away on its own. Roughly 40 to 50% of ground glass nodules regress or disappear entirely within three months, which strongly suggests they were caused by infection or temporary inflammation rather than anything worrisome. The average resolution time for these transient opacities is about 4.8 months.
This is why most guidelines recommend a follow-up CT scan rather than an immediate biopsy. For ground glass nodules larger than 10 mm, a repeat scan is typically recommended within three months. For smaller nodules (above 5 mm), the follow-up window extends to 6 to 12 months. If the opacity disappears on the repeat scan, no further workup is needed. If it persists or grows, further evaluation becomes necessary.
A nodule that stays stable for years is also reassuring, since the slow-growing nature of well-differentiated adenocarcinoma means that even nodules with precancerous potential often remain unchanged for extended periods. Long-term surveillance with periodic CT scans is the standard approach for persistent but stable ground glass nodules.
Why the Pattern Alone Doesn’t Tell the Whole Story
You might expect that the specific location or distribution of ground glass opacity would help narrow down the cause. In practice, this is less reliable than it sounds. A study in the American Journal of Roentgenology evaluated whether the pattern of GGO at the level of individual lung lobules could help differentiate between infections, inflammatory conditions, and other causes. It found no meaningful association between distribution pattern and diagnosis. Most diseases don’t stick to a single predictable pattern, which means radiologists rely heavily on the full clinical picture: your symptoms, medical history, lab results, and how the opacity changes over time.
This is why seeing “ground glass opacity” on a CT report doesn’t point to a single answer. The finding narrows the possibilities but almost always requires context to interpret. A GGO in someone with a fever and cough after a viral illness means something very different than the same finding in a long-term smoker with no symptoms, or in someone with known heart failure. The opacity is a starting point for figuring out what’s happening in the lungs, not the final word.